CD56 Is an Unfavorable Prognostic Factor for Acute Promyelocytic Leukemia: Results By Multivariate Analyses in the JALSG-APL204 Study

被引：0

作者：

Takeshita, Akihiro ^{[1
]}

Asou, Norio ^{[2
]}

Atsuta, Yoshiko ^{[3
]}

Furumaki, Hiroaki ^{[1
]}

Sakura, Toru ^{[4
]}

Ueda, Yasunori ^{[5
]}

Sawa, Masashi ^{[6
]}

Dobashi, Nobuaki ^{[7
]}

Suzuki, Rikio ^{[8
]}

Taniguchi, Yasuhiro ^{[9
]}

Nakagawa, Masaru ^{[10
]}

Tamaki, Shigehisa ^{[11
]}

Hagihara, Maki ^{[12
]}

Fujimaki, Katsumichi ^{[13
]}

Yokoyama, Yasuhisa ^{[14
]}

Fujita, Hiroyuki ^{[15
]}

Yanada, Masamitsu ^{[16
]}

Maeda, Yoshinobu ^{[17
]}

Usui, Noriko ^{[18
]}

Kobayashi, Yukio ^{[19
]}

Kiyoi, Hitoshi ^{[20
]}

Ohtake, Shigeki ^{[21
]}

Matsumura, Itaru ^{[9
]}

Naoe, Tomoki ^{[22
]}

Miyazaki, Yasushi ^{[23
]}

机构：

[1] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan

[2] Saitama Med Univ, Int Med Ctr, Hidaka, Saitama, Japan

[3] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan

[4] Saiseikai Maebashi Hosp, Leukemia Res Ctr, Maebashi, Gunma, Japan

[5] Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan

[6] Anjo Kosei Hosp, Anjo, Japan

[7] Jikei Univ, Dept Clin Oncol & Hematol, Daisan Hosp, Tokyo, Japan

[8] Tokai Univ, Sch Med, Isahara, Japan

[9] Kindai Univ, Fac Med, Osaka, Japan

[10] Nihon Univ, Sch Med, Tokyo, Japan

[11] Ise Red Cross Hosp, Ise, Japan

[12] Yokohama City Univ, Dept Hematol, Med Ctr, Yokohama, Kanagawa, Japan

[13] Fujisawa City Hosp, Fujisawa, Kanagawa, Japan

[14] Univ Tsukuba, Dept Hematol, Fac Med, Tsukuba, Ibaraki, Japan

[15] Yokohama City Univ, Dept Hematol & Clin Immunol, Grad Sch Med, Yokohama, Kanagawa, Japan

[16] Fujita Hlth Univ, Sch Med, Toyoake, Aichi, Japan

[17] Okayama Univ, Dept Hematol & Oncol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan

[18] Jikei Univ, Dept Internal Med, Div Clin Oncol & Hematol, Sch Med, Tokyo, Japan

[19] IUHW Mita Hosp, Div Hematol, Tokyo, Japan

[20] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi, Japan

[21] Kanazawa Univ, Kanazawa, Ishikawa, Japan

[22] Nagoya Med Ctr, Natl Hosp Org, Nagoya, Aichi, Japan

[23] Nagasaki Univ, Atom Bomb Dis Inst, Nagasaki, Japan

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-111638

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2798

引用

页数：3

共 50 条

[31] CD56 and PGP are independent negative prognostic factors for chemotherapy response in acute myeloid leukemia.
Raspadori, D
Damiani, D
Michelutti, A
Lenoci, M
Michieli, M
Tozzi, M
Lauria, F
BLOOD, 2001, 98 (11) : 194B - 194B
[32] Acute promyelocytic leukemia (APL): Therapy results and prognostic factors over a 23-year period.
Thomas, X
Belhabri, A
TreilleRitouet, D
Fiere, D
Archimbaud, E
BLOOD, 1995, 86 (10) : 676 - 676
[33] Expression of CD56 is a risk factor for acute lymphocytic leukemia with central nervous system involvement in adults
Hu, Wangqiang
Wang, Xiaoxia
Yang, Rongrong
Bi, Laixi
Xie, Yaosheng
Zhang, Zhuo
Lu, Hong
Wu, Lianfeng
HEMATOLOGY, 2017, 22 (02) : 81 - 87
[34] Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patients
Aref, Salah
Azmy, Emad
El-bakry, Kadry
Ibrahim, Lobna
Aziz, Sherin Abdel
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2017, 34 (05) : 275 - 285
[35] Preliminary results from the north American acute promyelocytic leukemia (APL) study C9710.
Powell, Bayard L.
Moser, Barry
Stock, Wendy
Gallagher, Robert E.
Willman, Cheryl L.
Stone, Richard M.
Rowe, Jacob M.
Coutre, Steven
Feusner, James H.
Gregory, John
Couban, Stephen
Appelbaum, Frederick R.
Tallman, Martin S.
Larson, Richard A.
BLOOD, 2006, 108 (11) : 171A - 171A
[36] Predictable prognostic factor of CD56 expression in acute myeloid leukemia with t(8:21) including allogeneic hematopoietic stem cell transplantation
Yang, DH
Mun, YC
Shin, HJ
Kim, YK
Lee, JJ
Jin, CY
Seong, CM
Kim, HJ
BLOOD, 2005, 106 (11) : 919A - 920A
[37] Prognostic Impact of Chromosomal Variation in Patients with Acute Promyelocytic Leukemia (APL); Analysis of 775 Cases Enrolled in the Japan Adult Leukemia Study Group APL Studies
Adachi, Miwa
Takeshita, Akihiro
Taki, Tomohiko
Ohtake, Shigeki
Shinagawa, Katsuji
Kiyoi, Hitoshi
Matsuda, Mitsuhiro
Takahashi, Masatomo
Emi, Nobuhiko
Kobayashi, Yukio
Miyamura, Koichi
Fujita, Hiroyuki
Sakura, Toru
Iwanaga, Masako
Usui, Noriko
Miyawaki, Shuichi
Asou, Norio
Ohnishi, Kazunori
Miyazaki, Yasushi
Naoe, Tomoki
BLOOD, 2014, 124 (21)
[38] CD56 ANTIGEN EXPRESSION AS THE MOST IMPORTANT PROGNOSTIC FACTOR IN NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA WITHOUT THE FLT3-ITD MUTATION
Djunic, I.
Virijevic, M.
Novkovic, A.
Kraguljac-Kurtovic, N.
Djurasinovic, V.
Colovic, N.
Vidovic, A.
Suvajdzic-Vukovic, N.
Tomin, D.
HAEMATOLOGICA, 2012, 97 : 24 - 25
[39] Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group
C Callens
S Chevret
J-M Cayuela
B Cassinat
E Raffoux
S de Botton
X Thomas
A Guerci
N Fegueux
A Pigneux
A-M Stoppa
T Lamy
F Rigal-Huguet
A Vekhoff
S Meyer-Monard
A Ferrand
M Sanz
C Chomienne
P Fenaux
H Dombret
Leukemia, 2005, 19 : 1153 - 1160
[40] Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL):: a retrospective study from the European APL Group
Callens, C
Chevret, S
Cayuela, JM
Cassinat, B
Raffoux, E
de Botton, S
Thomas, X
Guerci, A
Fegueux, N
Pigneux, A
Stoppa, AM
Lamy, T
Rigal-Huguet, F
Vekhoff, A
Meyer-Monard, S
Ferrand, A
Sanz, M
Chomienne, C
Fenaux, P
Dombret, H
LEUKEMIA, 2005, 19 (07) : 1153 - 1160

← 1 2 3 4 5 →